Cutis marmorata telangiectatica congenita | |
---|---|
Other names | Van Lohuizen syndrome |
Cutis marmorata telangiectatica congenital is inherited in an autosomal recessive manner[1] | |
Specialty | Dermatology |
Cutis marmorata telangiectatica congenita (CMTC) is a rare congenital vascular disorder that usually manifests in affecting the blood vessels of the skin. The condition was first recognized and described in 1922 by Cato van Lohuizen,[2] a Dutch pediatrician whose name was later adopted in the other common name used to describe the condition – Van Lohuizen syndrome. CMTC is also used synonymously with congenital generalized phlebectasia, nevus vascularis reticularis, congenital phlebectasia, livedo telangiectatica, congenital livedo reticularis and Van Lohuizen syndrome.[3]
It should not be confused with the more general term "cutis marmorata", which refers to livedo reticularis caused by cold.[4]
For a full and up-to-date description visit the CMTC webpages of the global non-profit patient organisation for people with CMTC and other vascular malformation CMTC-OVM: www.cmtc.nl/en